NLRP3 and pyroptosis blockers for treating inflammatory diseases. (2022)

First Author: Coll RC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.tips.2022.04.003

PubMed Identifier: 35513901

Publication URI: http://europepmc.org/abstract/MED/35513901

Type: Journal Article/Review

Volume: 43

Parent Publication: Trends in pharmacological sciences

Issue: 8

ISSN: 0165-6147